A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Genevieve M. Boland et al.|Cell|2018Cited by 1.5k
A molecular single-cell lung atlas of lethal COVID-19Johannes C. Melms, Benjamin Izar, Jana Biermann et al.|Nature|2021Cited by 735
Molecular Pathways of Colon Inflammation Induced by Cancer ImmunotherapyAdrienne Luoma, Kai W. Wucherpfennig, Shengbao Suo et al.|Cell|2020Cited by 478
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapyAdrienne Luoma, Kai W. Wucherpfennig, Shengbao Suo et al.|Cell|2022Cited by 376
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell CarcinomaJonathan D. Schoenfeld, Robert I. Haddad, Glenn J. Hanna et al.|JAMA Oncology|2020Cited by 350